Pharmaceutical Care in Community Pharmacies: Practice and Research from Around the World

2005 ◽  
Vol 39 (9) ◽  
pp. 1539-1541 ◽  
Author(s):  
Karen B Farris ◽  
Fernando Fernandez-Llimos ◽  
SI (Charlie) Benrimoj

Pharmaceutical care models and practices differ in various countries. Reimbursement for cognitive services, for example, varies across countries in Europe, Asia, and the Americas. Practice-based research has blossomed in many countries, with different emphases and challenges. This international series will describe the organization of community pharmacy within the healthcare system and report the status of practice-based research. Each paper will focus on one country. The series will conclude with a summary by the series editors describing the key themes across the papers, outlining milestones yet to be achieved, and proposing a research agenda for community pharmacy practice.

2020 ◽  
Vol 60 (6) ◽  
pp. 951-956
Author(s):  
Jenny S. Li ◽  
Victoria Blake ◽  
Samantha George ◽  
Joni C. Carroll ◽  
Melissa A. Somma McGivney ◽  
...  

2012 ◽  
Vol 3 (2) ◽  
Author(s):  
Margie E. Snyder ◽  
Caitlin K. Frail ◽  
Lindsey V. Seel ◽  
Kyle E. Hultgren

In 2010, the Purdue University College of Pharmacy established the Medication Safety Research Network of Indiana (Rx-SafeNet), the first practice-based research network (PBRN) in Indiana comprised solely of community pharmacies. In the development of Rx-SafeNet and through our early project experiences, we identified several "lessons learned." We share our story and what we learned in an effort to further advance the work of the greater PBRN community. We have formed the infrastructure for Rx-SafeNet, including an Executive Committee, Advisory Board, member pharmacies/site coordinators, and Project Review Team. To date, 22 community pharmacies have joined and we have recently completed data collection for the network's first project. Lessons learned during the development of Rx-SafeNet may benefit PBRNs nationally. Although community pharmacy PBRNs are not yet commonplace in the U.S., we believe their development and subsequent research efforts serve as an important avenue for investigating medication use issues.   Type: Idea Paper


2015 ◽  
Vol 23 (5) ◽  
pp. 361-366 ◽  
Author(s):  
Jayne L. Astbury ◽  
Cathal T. Gallagher ◽  
Richard C. O'Neill

1994 ◽  
Vol 7 (6) ◽  
pp. 246-248
Author(s):  
Gene A. Memoli

Pharmacists of the 1990s must anticipate a continued decline in their distributive role and a continuing expansion in their nondistributive role. The Pharmaceutical Care model will lead to the further development and expansion of nondistributive services that are knowledge-based. Cognitive Services, the pharmacy service model center to the Pharmaceutical Care model, will become more important to the practice. Now that many pharmacists have implemented Cognitive Services and are receiving reimbursement for these services, we will see continued growth. Many of our colleagues are receiving reimbursement for Cognitive Services on a regular basis both from the payors and the patient. The mechanisms (ie, written documentation, patient clearance, claim generation) are now presently documented and used in community pharmacy practice. The HCFA form 1500 is a standard form for submitting claims. The documentation and mechanisms required to achieve reimbursement for Cognitive Services are discussed in this article. Proper documentation of the need for care and the services (interventions) provided by the pharmacist are essential to achieving full reimbursement.


2005 ◽  
Vol 39 (9) ◽  
pp. 1527-1533 ◽  
Author(s):  
Erika JM Jones ◽  
Neil J MacKinnon ◽  
Ross T Tsuyuki

OBJECTIVE: To discuss the provision of pharmaceutical care in community pharmacies in Canada including the following topics: organization and delivery of health services, health service policy, methods of payment, types of pharmacy services provided, types of cognitive pharmacy services, research in community pharmacy, and future plans for community pharmacy services. DATA SYNTHESIS: The implementation of pharmaceutical care in Canadian community pharmacies continues to become more widespread. However, barriers to the provision of pharmaceutical care still exist, including the current shortage of pharmacists and lack of reimbursement systems for cognitive services. Evidence of the value of pharmaceutical care in Canadian community pharmacies has been supported by several pharmacy practice research projects. The pharmacist's role in patient care is expected to continue to expand. CONCLUSIONS: Although Canadian pharmacists' capabilities are not yet universally recognized and applied to their full potential, there is reason to be optimistic about the future of pharmaceutical care in the community setting in Canada.


2005 ◽  
Vol 39 (10) ◽  
pp. 1720-1725 ◽  
Author(s):  
JW Foppe van Mil

OBJECTIVE: To describe the pharmaceutical care activities and research in community pharmacy in the Netherlands. FINDINGS: Pharmaceutical care is well advanced in Dutch pharmacy practice. This is largely due to the fact that clinical pharmacy was already an integrated part of community pharmacy practice by the end of the 1980s. Activities of the International Pharmaceutical Federation (FIP), some wholesale companies, and influential individuals in the Netherlands stimulated universities and the Royal Society for the Advancement of Pharmacy to advance the implementation of pharmaceutical care. DISCUSSION: Not all pharmacies in the Netherlands provide pharmaceutical care at the same level, although medication surveillance (concurrent and prospective medication analysis) is part of everyday practice. Implementation of quality assurance systems in community pharmacy practice could be helpful in assuring high levels of care. Similar to those in other countries, Dutch pharmacists are torn between the wish to provide pharmaceutical care and economic considerations, although the financial status of most pharmacies is still (very) healthy. New entrants into the market, such as supermarket and pharmacy chains, seem to put little emphasis on care provision. CONCLUSIONS: Pharmaceutical care has been implemented in many Dutch community pharmacies, but not everywhere to the same extent. Due to excellent automated medication surveillance; structured, high-quality medication counseling; and the fact that patients usually visit the same pharmacy, Dutch patients are well protected against many drug-related problems.


2015 ◽  
Vol 6 (2) ◽  
Author(s):  
Mary Ann Kozak ◽  
Stephanie A. Gernant ◽  
Heather M. Hemmeger ◽  
Margie E. Snyder

Community pharmacy practice-based research networks (CP PBRNs) are a relatively new arena for pharmacists. While some lessons may be gleaned from primary care PBRNs, the experiences of CP PBRNs have much to offer the profession in terms of organization and practice. In 2012, we reported on our early experiences developing the Medication Safety Research Network of Indiana (RxSafeNet) after establishing the Network in 2010. Over the past 3 years, our CP PBRN of approximately 180 members has managed further growth by revisiting policies and procedures, maintaining CP PBRN member relationships, and preparing for financial sustainability. We look forward to furthering our CP PBRN projects in the coming years and collaborating with other CP PBRNs to enhance medication safety in Indiana and beyond.   Type: Original Research


Sign in / Sign up

Export Citation Format

Share Document